We have carried out a mutational analysis of the mouse IgH enhancer. Consistent with previous reports, deletions extending from either the 5'side or the 3'side of the enhancer fail to reveal distinct boundaries which define enhancer function in lymphoid cells. Interestingly, internal point mutations and deletions within the "enhancer core" regions fail to Identify any necessary functional role for these conserved elements. When tested in CV1 cells, which do not normally respond to the IgH enhancer, certain deletions exhibit significant enhancer activity. We take these findings to Indicate that the functional domains of the IgH enhancer are complex and that cell type specificity 1s defined 1n part by negative factors present 1n non-lymphoid cells.
INTRODUCTION
Enhancers are regions of DMA that act 1n ds to increase the rate of transcription of nearby genes. The unique property that defines these elements 1s their abil 1ty to function from distances of up to several kilobases when located either 3' or 5* to a gene (1). The mechanism by which enhancers function is unknown. It has been postulated that they may act as bidirectional "entry sites" for RNA polymerase or as DNA topoisomerase binding sites. Recent experiments Indicate that they bind and can compete for cellular factors (2,3,4,5). Although many enhancers are active in a large variety of cell types, relatively little homology at the level of DNA sequence is observed between enhancers: a finding that suggests that the cellular components that interact with enhancers are complex.
The enhancers located in the J-C Intron of the kappa and heavy chain immunoglobulin genes display the features of classical enhancer elements. Unlike most of their viral counterparts which show only slight variations 1n "host range", the Immunoglobulin enhancers are active only in lymphoid cells (6, 7, 8, 9) . This cell type specificity, taken with the particular location of these enhancer elements within the genes led to an elegant model of Immunoglobulin transcriptional activation 1n B lymphocytes. It was reasoned that unrearranged V genes would be transcriptionally inert simply because they are not in the vicinity of the enhancer element. Upon rearrangement, they would come under the Influence of the enhancer and thus be transcribed, leading to a mature Immunoglobulin mRNA. Recent evidence Indicating 1) that certain V genes are transcriptionally active before rearrangement (10) and 2) that the enhancer may be dispensable 1n late stages of B cell development (11, 12) suggests that regulation of immunoglobul 1n genes 1s far more intricate.
The Initial studies that defined the murine heavy chain enhancer mapped the functional elements qualitatively to a region of DNA comprising approximately 700 nucleotides with DNA fragments as small as 140 nucleotides possessing some activity (6,7). Surveys of the nucleotide sequences within the enhancer element reveal the presence of three regions that bear homology to enhancer "core" sequences and one octanucleotide that is highly conserved within the promoters of both heavy and light chain Immunoglobul1n genes (13,14). The importance of these conserved sequences was not established 1n those Initial studies. In addition to these four, Ephrussi, fil a]_. (4) Identified four additional elements defined by regions that exhibit perturbed patterns of methylation when nuclei of lymphoid cells are treated with DMS. The early deletion studies of the enhancer clearly Indicate that all four of these latter elements are not simultaneously required for enhancer function.
We have carried out a mutational analysis of the murine IgH enhancer using a transient assay system consisting of the gene encoding chloramphenicol acetyltransf erase linked to the human beta globin promoter. Deletion mutants and site-directed point mutants have been linked to this transcription unit and tested for enhancer function upon transfection of both lymphoid and non-lymphoid cells. Our results Indicate that the conserved "core" sequence elements may play only a minor role 1n enhancer function and that cell type specificity 1s, in part, negatively controlled.
MATERIALS AND HETHODS Plasmid DNAs
All plasraids were constructed using standard techniques (33). The plasmid pSVABGcat(x) (see Figure 1 ) represents a modification of pSV2cat (15) in which the SV40 early promoter has been replaced with the human beta globin promoter. The human beta globin promoter DNA fragment was deleted from the 3' side to a position one nucleotide past the Initiating ATG and modified by the addition of a Hind III linker (T.K., 1n preparation). Figure 2 and, with the exception mentioned below, these sites were modified with either Xba I linkers or Eco RI linkers for subcloning into pSVABGcat(x). All deletion mutants were inserted Into pSVABGcat(x) in the same orientation relative to the CAT gene as found 1n the heavy chain Intervening sequence. Deletions Involving the Pst I site of the enhancer were not modified with Xba I linkers, but cloned directly into pSVABGcat(x) using the Pst I site in the plasmid.
Deletion mutations of the IgH enhancer employ the natural restriction sites Indicated in
Mutagenesis was carried out using H13 phage and synthetic oligonucleotides essentially as described by Kunkel In experiments where CATase levels were normalized, taking into account the efficiency of the transfections, a plasmid expressing the human growth hormone gene from the HSV TK promoter and SV40 enhancer was included 1n each transfection (pSVTKGH). Growth hormone was assayed in the media of each flask as described (35) and this level was used to adjust the corresponding levels of CATase obtained.
RESULTS

Deletion analysis of the IgH enhancer.
The assay system used for our studies of enhancer activity 1s illustrated In Figure 1 . The test plasmid contains pBR322 sequences linked to a hybrid eukaryotic transcription unit consisting of the bacterial CAT gene (encoding chloramphenicol acetyltransferase; CATase (15)) linked to the human beta globin promoter. We chose the CAT gene because of the sensitivity with which Its expression can be detected and assayed and the beta globin promoter because of its profound transcriptional sensitivity to enhancer elements. The beta globin promoter has also been shown to correctly Table One ).
Note that the activity of the various deletions coming 1n from either side of the enhancer does not drop precipitously with any one deletion. Rather, the enhancer activity falls off gradually as DNA is removed from either side, leading finally to an activity of only ten percent of wild type when the Pvu 11 to Dde I fragment 1s used (Deletion #12; 140 bp). This gradual drop off 1s not due to redundancies 1n the functional components of the enhancer Inasmuch as the relative effects of the 5' deletions are Independent of which 3' end 1s present and the relative effects of the 3 1 deletions are Independent of which 5' endpoints are used. However, when we tested plasmids that contain either one, two or three copies of fragment 12 (linked head to tall) or that contain either one, two or three copies of fragment 2, we observed a dose response of CATase expression to the number of enhancers present in the plasmid. This result would suggest that we could build a perfectly good enhancer just by employing the elements present on fragment 12 (to be presented elsewhere).
The nucleotide sequence of the central region of the enhancer element 1s shown 1n Figure 3 (Deletion #6, Fig.2) , illustrating the conserved sequence elements postulated to be Important for enhancer function. These include the three enhancer core elements (Cl, C2 and C3), the octanucleotide ATTTGCAT (8mer) and the four eleraents defined by the perturbed DMS methyl atlon patterns observed 1n Isolated nuclei of B cells (El, E2, E3 and E4). Also shown are the endpoints of our deletion mutants that map within this region. Note that simultaneous deletion of the octanucleotide and E4 (F1g.2, deletion 19) still retain roughly 50 percent of wild type enhancer activity. These (Fig.2, deletions #3 and #4 ) also retain substantial enhancer activity, albeit lower than wild type levels. We conclude that these particular elements, while perhaps influencing the level of enhancer activity, are not absolutely essential. Mutations within enhancer core elements.
In order to test the functional Importance of the "core elements" (Cl, C2 and C3) within the IgH enhancer, we point mutagenized each of these three elements and then tested the effect on enhancer activity 1n the context of the large Eco RI to Xba I DNA fragment (Fig. 2) . Specifically, we created Bam HI restriction sites at each locus 1n order to unambiguously destroy each consensus sequence and to ease the Identification and further manipulation of these mutant enhancers (see F1g. 3 for nucleotide substitutions). As shown 1n Table One, none of the three mutants, Ml, M2 and M3 (corresponding to Cl, C2 and C3, respectively) showed any significant diminution 1n enhancer activity.
In light of the degree to which these core elements are conserved between the SV40 enhancer, the polyoma enhancer and the IgH enhancer, this result was surprising to us. However, we reasoned that perhaps only two of the three or perhaps only one the three core elements 1s necessary for the enhancer to function. Instead of creating all the combinations of Ml, M2 Table One , none of these internal deletions had an appreciable effect on enhancer function. We therefore conclude that the enhancer core elements do not play a critical role in enhancer activity 1n lymphoid cells. Activity of enhancer deletions in CV1 cells. In addition to testing our various enhancer molecules 1n the B lymphoid cell line, P3-X63Ag8, we also tested them 1n CV1 cells, a monkey epithelial cell line (20) . It has been reported that the IgH enhancer has no activity in a variety of non-B cells such as HeLa (7), and mouse L (6) cells. We have confirmed that this is also the case for CV1 cells using the large Xba I to Eco RI restriction fragment. However, when we examine the activity of the various deletions in CV1 cells we see the very striking result shown in 
DISCUSSION
We have carried out a functional analysis of the murine heavy chain enhancer. The assay system we have employed for this analysis relies on the ability of the enhancer to stimulate transcription of a hybrid transcription unit consisting of the human beta globin promoter linked to the CAT gene. It has previously been shown that the IgH enhancer stimulates proper Initiation at the beta globin promoter (7) and that levels of CATase can be used to conveniently measure transcriptional activity (15). We have not re-conf1rmed those findings 1n our present study because 1) our various enhancer constructions do not physically disrupt the primary transcript and 2) the enhancers are placed 3' to the transcription unit and should therefore not Interfere with utilization of the promoter elements per se. Because of the relatively large distance between the enhancers and the promoter, we have only determined the activity of the enhancers in the orientation that naturally occurs in the heavy chain gene. Although the assay system 1s artificial (I.e. it does not measure heavy chain gene transcription directly), and 1s thus limited 1n Its ability to address more general questions concerning imraunoglobulin gene regulation, we feel that is suited for the Isolated examination of the IgH enhancer element.
Our results using transfections into lymphoid cells Indicate that the DNA sequences important for activity of the heavy chain enhancer cannot be strictly defined. The essential elements are spread over a fairly large region of DNA ( >220 bp) with no distinct boundary defining the enhancer. Our deletions therefore confirm the results of others which also indicate that enhancer activity 1s spread over a rather broad stretch of DNA (6,7). Our finding that the enhancer core elements are dispensable for activity 1s more surprising. These elements are highly homologous to those found in the SV4O and polyoma enhancers and are also conserved 1n the human heavy chain enhancer (although the core elements are not the only enhancer sequences conserved between mouse and human (21)). It 1s generally believed that conservation of DNA sequence is a hallmark of functional Importance, yet we have been unable to confirm this for the IgH enhancer. It 1s possible, however, that these sequences possess a function that 1s not detected by our assay.
The role of the conserved octanucleotide, ATTTGCAT, in the enhancer is particularly intriguing. This element is present not only in the mouse heavy chain enhancer (conserved at 7/8 nucleotides 1n human), but also in both the heavy chain and kappa promoters; 1n opposite orientations to one another (13,14) . Recent evidence suggests that a common cellular protein binds to the octanucleotide present 1n each of these three elements (5). Our results indicate that this conserved octanucleotide is not critical for enhancer function, even though we have not yet demonstrated by point mutagenesis that 1t has no effect. The recent demonstration of promoter activity 1n the vicinity of the heavy chain enhancer suggests a more likely role for the conserved octanucleotide; namely as a promoter element (26) . It has been shown that a region of the heavy chain promoter containing the octanucleotide 1s essential for promoter activity (23) and 1t 1s possible that our deletions would have a similar effect if they were tested for promoter activity per se.
We have shown that the cell type specificity displayed by the IgH enhancer is due in part to negative control. That 1s, we have identified mutations within the enhancer that lead to a substantial Increase in enhancer activity 1n non-lympho1d cells. As mentioned above, the most pronounced effect is observed 1n those DNA fragments which have been deleted to the Pvu II site just 5' of the core elements. However, deletions which extend from the 3' side of the enhancer also have an effect since deletion #12 gives more activity than either Deletion #4 or Deletion #8 (Fig. 2) . We have noted that this activity 1s still low compared to the SV40 enhancer (5%) and is also sensitive to the efficiencies of our transfections (the better the transfection, the more pronounced the effect). However, even though the activity 1s low, 1t should be kept in mind that these same mutations have an adverse affect on the activity of the enhancer 1n lymphoid cells. Hence, they likely have an adverse affect on the "potential" enhancer activity in CV1 cells as well. It 1s possible that both lymphoid and CV1 cells express the same factors capable of activating the IgH enhancer, but that CV1 cells also possess factors capable of inhibiting this activation.
Recently, Wasylyk and Wasylyk (36) have reported similar findings for the IgH enhancer. They have shown that, when placed immediately 5' to either a beta globin or conalbumin promoter, certain deletions of the enhancer are active in non-lymphoid cells. Consistent with our results, the enhancer fragment that they obtain the highest activity with 1n fibroblast cells extends from the Pvu II to Dde I restriction sites (our Fragment 12). They also note that the relatively low activity of the IgH enhancer is influenced by the efficiency of transfection. However, one inconsistency between the two sets of experiments lies in our ability to measure the enhancement at a distance (1.6 kb). They state that they cannot observe enhancement 1n fibroblasts unless the enhancer 1s located adjacent to the promoter. The reason for this discrepancy is not clear, but may be related to the particular DNA sequences that lie between the promoter and enhancer 1n their plasmids.
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